Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,625 | -31 | -29 | -27 | -27 |
| Depreciation Amortization | 191 | N/A | N/A | N/A | N/A |
| Accounts receivable | -400 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 2 | -2 | -1 | 1 |
| Other Working Capital | 1,403 | 15 | 5 | 3 | 4 |
| Other Operating Activity | 3,506 | -2 | 2 | 1 | -1 |
| Operating Cash Flow | $-17,925 | $-16 | $-23 | $-24 | $-23 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -70,562 | N/A | N/A | N/A | N/A |
| PPE Investments | -64 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-70,626 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 15 | 25 | 25 | N/A |
| Debt Issued | 5,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 97,870 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $102,870 | $15 | $25 | $25 | $N/A |
| Beginning Cash Position | 1,124 | 7 | 5 | 4 | 27 |
| End Cash Position | 15,443 | 6 | 7 | 5 | 4 |
| Net Cash Flow | $14,319 | $-1 | $2 | $1 | $-23 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,925 | -16 | -23 | -24 | -23 |
| Capital Expenditure | -64 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -17,989 | -16 | -23 | -24 | -23 |